Skip to content

Distinct acute effects of LSD, MDMA, and d-amphetamine in healthy subjects

Friederike Holze, Patrick Vizeli, Felix Müller, Laura Ley, Raoul Duerig, Nimmy Varghese, Anne Eckert, Stefan Borgwardt, Matthias E. Liechti

Neuropsychopharmacology November 16, 2019 DOI: 10.1038/s41386-019-0569-3 via OpenAlex

Summary

AI-generated from the abstract

LSD, MDMA, and d-amphetamine all increased heart rate, blood pressure, body temperature, and pupil size, but LSD produced the strongest alterations in consciousness, mystical experiences, ego dissolution, and emotional excitation. MDMA increased feelings of good drug effects, liking, and high more than d-amphetamine, and only MDMA raised oxytocin levels. d-Amphetamine boosted activity and concentration relative to LSD. None of the substances changed brain-derived neurotrophic factor. The findings highlight distinct subjective and endocrine profiles that may inform dosing in psychedelic-assisted therapy.

Study at a glance

Characteristics Randomized, double-blind, cross-over study Peer reviewed
Sample size 28
Population Healthy subjects
Interventions LSD MDMA d-amphetamine placebo
Dose 0.1 mg LSD, 125 mg MDMA, 40 mg d-amphetamine
Topics LSD MDMA
Keywords Hallucinogen Psychology Stimulant
Citations 250
Key finding LSD, MDMA, and d-amphetamine produce comparable autonomic responses but clearly distinct subjective and endocrine effects.

Abstract

Abstract Lysergic acid diethylamide (LSD) is a classic psychedelic, 3,4-methylenedioxymethamphetamine (MDMA) is an empathogen, and d -amphetamine is a classic stimulant. All three substances are used recreationally. LSD and MDMA are being investigated as medications to assist psychotherapy, and d -amphetamine is used for the treatment of attention-deficit/hyperactivity disorder. All three substances induce distinct acute subjective effects. However, differences in acute responses to these prototypical psychoactive substances have not been characterized in a controlled study. We investigated the acute autonomic, subjective, and endocrine effects of single doses of LSD (0.1 mg), MDMA (125 mg), d -amphetamine (40 mg), and placebo in a randomized, double-blind, cross-over study in 28 healthy subjects. All of the substances produced comparable increases in hemodynamic effects, body temperature, and pupil size, indicating equivalent autonomic responses at the doses used. LSD and MDMA increased heart rate more than d -amphetamine, and d -amphetamine increased blood pressure more than LSD and MDMA. LSD induced significantly higher ratings on the 5 Dimensions of Altered States of Consciousness scale and Mystical Experience Questionnaire than MDMA and d -amphetamine. LSD also produced greater subjective drug effects, ego dissolution, introversion, emotional excitation, anxiety, and inactivity than MDMA and d -amphetamine. LSD also induced greater impairments in subjective ratings of concentration, sense of time, and speed of thinking compared with MDMA and d -amphetamine. MDMA produced greater ratings of good drug effects, liking, high, and ego dissolution compared with d -amphetamine. d -Amphetamine increased ratings of activity and concentration compared with LSD. MDMA but not LSD or d -amphetamine increased plasma concentrations of oxytocin. None of the substances altered plasma concentrations of brain-derived neurotrophic factor. These results indicate clearly distinct acute effects of LSD, MDMA, and d -amphetamine and may assist the dose-finding in substance-assisted psychotherapy research.

Explore topics

Comments

No comments yet.

Log in to comment